Binding and uptake of MPTP by preparations of human and animal brain.
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is known to cause parkinsonism in man and animals, producing acute behavioral effects within minutes of administration. This syndrome has been attributed to specific effects on dopaminergic systems. MPTP blocked the binding of haloperidol to membranes from rat and human brain (IC(50) = 2.5 ?M), but it did not block the binding of flupenthixol to these membranes. These results indicate that MPTP is a ligand for D-2 dopamine receptors but not for D-1 dopamine receptors. Synaptosomes from rat, mouse or guinea-pig corpus striatum or from monkey caudate nucleus exhibited little ability to take up MPTP from the incubation medium. The synaptosomes took up at least 20-50 times more dopamine than MPTP. These results indicate that MPTP could cause acute effects by binding to dopamine receptors and that the specific toxicity MPTP exerts for dopaminergic neuron is not primarily based on the specific uptake of MPTP into these neurons.